Report of the 2023-2024 Strategic Engagement Standing Committee

被引：0

作者：

Palombi, Laura C. ^{[1
]}

Silvia, Richard ^{[2
]}

Dugan, Sara ^{[3
]}

Khan, Md Omar Faruk ^{[4
]}

Kawahara, Brian I. ^{[5
]}

O'Neal, Katherine S. ^{[6
]}

Robinson, Evan ^{[7
]}

Tyler, Linda ^{[8
]}

Unni, Elizabeth ^{[9
]}

Shrader, Sarah ^{[10
]}

Moore, Terri ^{[10
]}

机构：

[1] Univ Minnesota, Coll Pharm, Duluth, MN 55812 USA

[2] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA

[3] Northeast Ohio Med Univ, Rootstown, OH USA

[4] Univ Charleston, Sch Pharm, Charleston, WV USA

[5] Chapman Univ, Sch Pharm, Irvine, CA USA

[6] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK USA

[7] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE USA

[8] Univ Utah, Coll Pharm, Salt Lake City, UT USA

[9] Touro Coll Pharm, New York, NY USA

[10] Amer Assoc Coll Pharm, Arlington, VA USA

来源：

AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION | 2024年 / 88卷 / 08期

关键词：

AACP; Advocacy; Champions; Partnerships; Stakeholders;

D O I：

10.1016/j.ajpe.2024.100752

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

The American Association of Colleges of Pharmacy has long emphasized the value of strategic engagement, recognizing that it is critical to the success of pharmacy education, contributing to the expansion of pharmacy and public health practice, the fulfillment of institutional missions, and the meeting of programmatic needs. The 2023-2024 Strategic Engagement Committee was charged with operationalizing advocacy champions, creating an advocacy resource guide to support advocacy champions in their engagement with diverse public and private stakeholders, offering formal training to advocacy champions in the form of a new connect community and webinar series, and conducting focus groups at the 2024 Annual Meeting to determine strengths of the advocacy guide and opportunities to support advocacy champions further.

引用

页数：4

共 50 条

[41] Current topic of vascular function in hypertension in 2023-2024
Maruhashi, Tatsuya
Higashi, Yukihito
HYPERTENSION RESEARCH, 2024, 47 (12) : 3310 - 3317
[42] Film review 2023-2024: Anatomy of a Palme (d'or)
Degroult, Nathalie
Bissiere, Michele
Brunet, Marie-Line
FRENCH REVIEW, 2025, 98 (03):
[43] New Pfizer and Moderna Vaccine Formulations for 2023-2024
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1687): : 167 - 168
[44] 2 The work of the British School at Athens, 2023-2024
Sweetman, Rebecca
ARCHAEOLOGICAL REPORTS, 2024, 70 : 11 - 42
[45] Protests in the United States on Palestine and Israel, 2023-2024
Chenoweth, Erica
Hammam, Soha
Pressman, Jeremy
Ulfelder, Jay
SOCIAL MOVEMENT STUDIES, 2024,
[46] Letter from the Editors of J Endourol: 2023-2024
Landman, Jaime
Sundaram, Chandru
Welch, Norbert
Welch, Louise
Gupta, Mantu
JOURNAL OF ENDOUROLOGY, 2023, 37 (10) : 1073 - 1074
[47] Antiviral Drugs for Influenza for 2023-2024 (vol 65, pg 177, 2023)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 192 - 192
[48] Characterizations of Certain (2023-2024) Introduced Univariate Continuous Distributions
Hamedani, G. G.
Roshani, Amin
Butt, Nadeem S.
PAKISTAN JOURNAL OF STATISTICS AND OPERATION RESEARCH, 2024, 20 (04) : 661 - 692
[49] Mpox clade II in France in 2023-2024: an endemic situation?
Rahi, Mayda
Fouere, Sebastien
Gilbert, Marie
Bachelard, Antoine
Taieb, Fabien
Sellem, Baptiste
Herms, Florian
Cazanave, Charles
Monsel, Gentiane
Yazdanpanah, Yazdan
Peiffer-Smadja, Nathan
Ghosn, Jade
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 307 - 309
[50] Reflecting on Progress of the Malaysian Journal of Medical Sciences: 2023-2024
Ismail, Siti Nor Qamariah
Abdullah, Jafri Malin
MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2024, 31 (06): : 1 - 5

← 1 2 3 4 5 →